ES2085003T3 - Uso de il-4 para mejorar la fase reparadora de la curacion y restaño de heridas y para mejorar la curacion de heridas infectadas y las heridas de mamiferos diabeticos. - Google Patents

Uso de il-4 para mejorar la fase reparadora de la curacion y restaño de heridas y para mejorar la curacion de heridas infectadas y las heridas de mamiferos diabeticos.

Info

Publication number
ES2085003T3
ES2085003T3 ES92904122T ES92904122T ES2085003T3 ES 2085003 T3 ES2085003 T3 ES 2085003T3 ES 92904122 T ES92904122 T ES 92904122T ES 92904122 T ES92904122 T ES 92904122T ES 2085003 T3 ES2085003 T3 ES 2085003T3
Authority
ES
Spain
Prior art keywords
wounds
improve
healing
rest
enhancing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92904122T
Other languages
English (en)
Inventor
Martin A Schwarz
Lee M Sullivan
Loretta A Bober
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2085003T3 publication Critical patent/ES2085003T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBE UN METODO PARA INTENSIFICAR LA FASE REPARADORA DE CURACION DE UNA HERIDA EN MAMIFEROS QUE INCLUYE LA APLICACION DE UNA CANTIDAD EFECTIVA DE IL-4 SOBRE EL LUGAR DE LA HERIDA DURANTE LA FASE REPARADORA, PREFERENTEMENTE DE FORMA TOPICA EN GEL DE COLAGENO,Y EN CANTIDAD SUFICIENTE.TAMBIEN SE DESCRIBEN LOS METODOS PARA CURAR Y ACELERAR LAS HERIDAS INFECTADAS, LAS HERIDAS EN MAMIFEROS DIABETICOS, Y LAS HERIDAS DE MAMIFEROS INMUNOCOMPROMETIDOS, EN ESTOS CASOS SE ADMINISTRA UNA CANTIDAD TERAPEUTICAMENTE EFECTIVA DE IL-4.
ES92904122T 1991-01-10 1992-01-07 Uso de il-4 para mejorar la fase reparadora de la curacion y restaño de heridas y para mejorar la curacion de heridas infectadas y las heridas de mamiferos diabeticos. Expired - Lifetime ES2085003T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63963191A 1991-01-10 1991-01-10

Publications (1)

Publication Number Publication Date
ES2085003T3 true ES2085003T3 (es) 1996-05-16

Family

ID=24564917

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92904122T Expired - Lifetime ES2085003T3 (es) 1991-01-10 1992-01-07 Uso de il-4 para mejorar la fase reparadora de la curacion y restaño de heridas y para mejorar la curacion de heridas infectadas y las heridas de mamiferos diabeticos.

Country Status (11)

Country Link
EP (2) EP0566661B1 (es)
JP (1) JPH0747545B2 (es)
AT (1) ATE135233T1 (es)
AU (1) AU660959B2 (es)
CA (1) CA2099263C (es)
DE (1) DE69209051T2 (es)
DK (1) DK0566661T3 (es)
ES (1) ES2085003T3 (es)
GR (1) GR3019708T3 (es)
IE (1) IE75707B1 (es)
WO (1) WO1992011861A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206345A (en) * 1990-08-02 1993-04-27 Fred Hutchinson Cancer Research Center Il-4 and tnf induce mab 6g10-recognized expression on bone marrow stromal cells
NZ263102A (en) * 1993-03-19 1997-05-26 Immunex Corp Pharmaceutical compositions comprising a ligand protein such as interleukin-4 and a soluble receptor protein that binds thereto
GB2304047A (en) 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
GB2430031A (en) * 2005-09-07 2007-03-14 Ethicon Inc Diagnostic markers of wound infection
EP4422668A1 (en) * 2021-10-25 2024-09-04 Ellennbe GmbH Pharmaceutical composition and kit comprising an immunomodulatory substance for treating diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT83761B (pt) * 1985-11-19 1989-06-30 Schering Biotech Corp Metodo para a producao de interleuquina-4 de mamifero
EP0302429B1 (en) * 1987-08-03 1993-07-28 Tasuku Honjo Novel human interleukin 4, expression vectors for human interleukin 4 and transformants containing the same
JPH0611706B2 (ja) * 1989-01-20 1994-02-16 ザ ユニバーシティ オブ メルボルン フィブリン溶解
KR100191223B1 (ko) * 1989-07-28 1999-06-15 둘락 노먼 씨. 인터루킨-4의 정제방법 및 이를 함유하는 약제학적 조성물
ZA912037B (en) * 1990-03-21 1992-03-25 Schering Corp Use of il-4 to enhance immune response to infectious antigenic challenges

Also Published As

Publication number Publication date
EP0502599A1 (en) 1992-09-09
WO1992011861A1 (en) 1992-07-23
EP0566661A1 (en) 1993-10-27
CA2099263C (en) 1997-03-11
AU1198092A (en) 1992-08-17
AU660959B2 (en) 1995-07-13
DK0566661T3 (da) 1996-07-01
JPH05509333A (ja) 1993-12-22
IE75707B1 (en) 1997-09-10
DE69209051D1 (de) 1996-04-18
CA2099263A1 (en) 1992-07-11
EP0502599B1 (en) 1996-03-13
IE920070A1 (en) 1992-07-15
ATE135233T1 (de) 1996-03-15
GR3019708T3 (en) 1996-07-31
DE69209051T2 (de) 1996-08-08
JPH0747545B2 (ja) 1995-05-24
EP0566661B1 (en) 1996-03-13

Similar Documents

Publication Publication Date Title
ES2060775T3 (es) Egf para la prevencion de daños en tejidos despues de un episodio isquemico.
FI924778A7 (fi) GM-CSF:n ja G-CSF:n käyttö haavojen paranemisen nopeuttamiseksi
DE69101316D1 (de) Empfänglichmachen von säugetieren für beschleunigte gewebereparatur.
ES2091906T3 (es) Composiciones que comprenden derivados de un peptido de omega-conotoxina y su uso en el tratamiento del daño neuronal relacionado con la isquemia.
ATE109352T1 (de) Heilung von wunden.
DE68917512D1 (de) Kosmetisches Präparat.
ES2081488T3 (es) Uso de fosfolipido en la fabricacion de un medicamento topico para modificar los niveles de colesterol serico.
ATE290397T1 (de) Formulierung fur die wundheilung mit menschlichem plasma fibronektin
AR004348A1 (es) Reduccion del crecimiento del cabello
DE69327263D1 (de) Verwendung des Gewebefaktor-Inhibitors zur Herstellung eines Arzneimittels gegen Mikrogefässthrombose
ES2063250T3 (es) Uso de la trombospondina para facilitar la curacion de las heridas.
MX6178E (es) Un procedimiento para la preparacion de una composicion facilmente removible y cicatrizante de heridas y quemaduras
DE58906031D1 (de) Topisch anwendbare pharmazeutische Zubereitung.
IT7869853A0 (it) Peptidi particolarmente utili in terapia e procedimento per la loropreparazione
ES2054098T3 (es) Uso de minoxidilo para la curacion de heridas.
ES2085003T3 (es) Uso de il-4 para mejorar la fase reparadora de la curacion y restaño de heridas y para mejorar la curacion de heridas infectadas y las heridas de mamiferos diabeticos.
ATE109001T1 (de) Mittel zur stimulierung der tränensekretion.
ATE151977T1 (de) Therapeutisch wirksame, örtliche anwendung von st1435
ES500704A0 (es) Perfeccionamientos en instrumentos para realizar suturas quirurgicas
DK0951294T3 (da) Sårhelende formuleringer indeholdende humanplasmafibronectin
ATA4993A (de) Topische zusammensetzung zur beschleunigung der wundheilung
BR9002240A (pt) Processo para a preparacao de uma composicao conservada apropriada para aplicacao topica a pele e composicao
IT8848208A0 (it) Uso terapeutico del derivato estere isopropilico del monosialogangliosi de in patologie ad interessamento nervoso con componente infiammatoria
DE69306559D1 (de) Neue kardioprotektive wirkstoffe
IT1069387B (it) Calza con parte a mutanda in tessuto elasticizzato per uso chirurgico o terapeutico in particolare per il contenimento delle vene varicose

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 566661

Country of ref document: ES